Suppr超能文献

输注白蛋白而非胶体可逆转利尿剂诱发的肝性脑病。

Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid.

作者信息

Jalan Rajiv, Kapoor Dharmesh

机构信息

Liver Failure Group, Institute of Hepatology, University College London Medical School, London WC1E 6HX, UK.

出版信息

Clin Sci (Lond). 2004 May;106(5):467-74. doi: 10.1042/CS20030357.

Abstract

In patients with cirrhosis, dehydration induced by diuretics is a common precipitant of hepatic encephalopathy (HE), which may respond to volume expansion. The mechanism of HE in this situation is not fully understood. The present study evaluates the effect of plasma volume expansion on the severity of HE, plasma and urinary ammonia in patients with diuretic-induced HE. Fifteen patients with alcoholic cirrhosis and diuretic-induced HE of Grade 2 or more were enrolled. In eight patients, 4.5% human albumin solution (HAS) was used for volume expansion and in seven patients colloid (Gelofusine) was used. Significant improvement of HE Grade was observed at 24 h and was sustained at 72 h ( P <0.05) only in the group treated with HAS. There were similar and statistically significant reductions in plasma ammonia concentration, plasma renin activity and angiotensin II and an increase in mean arterial pressure, renal plasma flow and urinary ammonia excretion in both groups. Plasma malondialdehyde was elevated in both groups, but was reduced significantly only in the group treated with HAS. The findings of the present study show that plasma volume expansion results in significant reduction in plasma ammonia concentration, possibly through an increase in urinary ammonia excretion. This reduction in ammonia concentration translates into an improvement in mental state only in those patients treated with HAS in whom concomitant reduction in oxidative stress was observed. These data support the notion that other factors, such as oxidative stress, act as adjuncts to ammonia in the pathogenesis of diuretic-induced HE and suggest a possible role for albumin infusion in its treatment.

摘要

在肝硬化患者中,利尿剂诱发的脱水是肝性脑病(HE)的常见诱因,扩容治疗可能有效。这种情况下HE的发病机制尚不完全清楚。本研究评估了血浆扩容对利尿剂诱发的HE患者的HE严重程度、血浆及尿氨的影响。纳入15例酒精性肝硬化且利尿剂诱发的HE为2级及以上的患者。8例患者使用4.5%人血白蛋白溶液(HAS)进行扩容,7例患者使用胶体液(聚明胶肽)。仅在使用HAS治疗的组中,24小时时观察到HE分级有显著改善,且在72小时时持续存在(P<0.05)。两组的血浆氨浓度、血浆肾素活性和血管紧张素II均有相似且具有统计学意义的降低,平均动脉压、肾血浆流量和尿氨排泄增加。两组的血浆丙二醛均升高,但仅在使用HAS治疗的组中显著降低。本研究结果表明,血浆扩容可使血浆氨浓度显著降低,可能是通过增加尿氨排泄实现的。氨浓度的降低仅在使用HAS治疗且观察到氧化应激同时降低的患者中转化为精神状态的改善。这些数据支持这样一种观点,即其他因素,如氧化应激,在利尿剂诱发的HE发病机制中作为氨的辅助因素起作用,并提示白蛋白输注在其治疗中可能发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验